This is an old revision of the document!
Vaccine Innovation Prioritisation Strategy
The Vaccine Innovation Prioritisation Strategy (VIPS) Alliance is a supranational collaborative initiative. It consists of the Bill & Melinda Gates Foundation, Gavi, the Vaccine Alliance, PATH, UNICEF and the World Health Organization.1)
Activities
Microarray patches
In May 2020, the VIPS Steering Committee selected and recommended three vaccine-related innovations to prioritize in order to increase uptake of vaccines. Microaray patches (MAPS) were identified as the highest priority (the other two were “heat-stable and controlled temperature chain qualified vaccines”, and barcodes on primary packaging).2) During the second half of 2020 and into 2021, the VIPS Working Group published a five-year plan to develop these MAPS.
MAPS are small devices that “consist of an array of hundreds to thousands of micro-projections on a patch or backing. These micro-projections can be coated with, or are composed of, vaccine in a dry formulation.”
1)
The Vaccine Innovation Prioritisation Strategy. (2021, June 30). Gavi, the Vaccine Alliance. https://archive.ph/eZMoO
2)
Vaccine Innovation Prioritisation Strategy (VIPS). (2021). Vaccine microarray patches (MAPs): public summary of the VIPS Alliance Action Plan (p. 2). Gavi, the Vaccine Alliance. https://web.archive.org/web/20220806221838/https://www.gavi.org/sites/default/files/about/market-shaping/VIPS-Alliance-Action-Plan-for-MAPS_Public-Summary.pdf